The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: -0.40 (-1.21%)
Spread: 1.40 (4.375%)
Open: 33.10
High: 33.20
Low: 32.70
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's dealing - Grant of Share Options

3 Aug 2015 09:55

RNS Number : 8611U
Mercia Technologies PLC
03 August 2015
 



3 August 2015

 

Mercia Technologies PLC

 

Director's dealing - Grant of Share Options

 

Mercia Technologies PLC (AIM: MERC, 'Mercia' or the 'Company') a Midlands-based investment group, building, funding and commercialising technology businesses across the UK, announces that on 31 July 2015, Matthew Mead, Chief Investment Officer and a director of Mercia, was awarded options over 1,000,000 new Ordinary shares with a nominal value of 0.001 pence each in the Company ('Ordinary shares') pursuant to the 2014 Mercia Company Share Option Plan.

 

Options over 42,857 new Ordinary shares, being the HMRC approved element of the award, vest and are exercisable in three equal annual tranches from 31 July 2018 at an exercise price of 70.0 pence, being the closing mid-market price on 30 July 2015, the day before the award. Options over the remaining 957,143 new Ordinary shares, being the unapproved element of the award, also vest and are exercisable in three equal annual tranches from 31 July 2018, but at an exercise price of 57.5 pence, being the closing mid-market price on 10 July 2015, the date that Mercia exited its recent close period. All options would have been granted to Matthew when he joined Mercia on 26 May 2015, had the Company not been in a close period on that date.

 

The awards are subject to the same performance condition applicable to the other Executive Directors, as set out in the Company's recently published Annual Report.

 

 

 Enquiries:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities (Nomad)

+44 (0) 20 7397 8900

Ivonne Cantu / Mark Connelly

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Lauren Foster

 

 

Note to editors

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands, the North and Scotland. It brings technology transfer, company formation, incubation, commercialisation and investment to technology ventures. Approximately 50% of its investments derive from university spinouts. Mercia invests across key technology sectors in which it has deep sector expertise.

 

The Mercia model is one of patiently nurturing businesses through its tax efficient third party funds under management, and then scaling them with direct investment at the point of commercial traction. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'. Currently, the Group has a direct investment in 18 operating companies and access to a portfolio of 44 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.

 

Mercia's shares started trading on AIM on 18 December 2014 and since then up until 31 March 2015, Mercia has invested approximately £12m directly across its portfolio of emerging stars, which in themselves have attracted a total investment of over £70m alongside investment from the Group to date. In addition to its direct investments, Mercia (via Mercia Fund Management) has invested over £19m to build its portfolio of potential emerging stars.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPKNDPFBKKNFK
Date   Source Headline
5th Jul 20227:00 amRNSPreliminary Results
27th Jun 20227:00 amRNSInvestor Presentation
23rd May 20227:00 amRNSNotice of Results
16th May 20227:00 amRNSPublication of ‘The Insight’ Newsletter
12th May 20227:00 amRNSMercia's EIS Funds raise c.£20million
26th Apr 202210:27 amRNSTR-1: Notification of major holdings
11th Apr 20227:00 amRNSUpdate on proceeds from sale of Faradion
1st Apr 202211:10 amRNSTR-1: Notification of major holdings
29th Mar 20227:00 amRNSnDreams receives significant new investment
10th Mar 20227:06 amRNSMercia’s Northern VCTs raise £40.0million
28th Feb 20227:00 amRNSFurther direct investment into MIP Diagnostics
18th Feb 20229:49 amRNSTR-1: Notification of major holdings
5th Jan 202212:36 pmRNSDirector/PDMR Dealings
5th Jan 20227:00 amRNSCompletion of the sale of Faradion
31st Dec 20217:00 amRNSSale of Faradion Limited
22nd Dec 20217:00 amRNSFurther direct investment into Intechnica Group
7th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSSoccer Manager secures significant new licences
25th Nov 20217:00 amRNSNVT performance fee entitlement and trading update
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.